The Natively Disordered Loop of Bcl-2 Undergoes Phosphorylation-Dependent Conformational Change and Interacts with Pin1

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Kang, CongBao ^a,b   Bharatham, Nagakumar ^a   Chia, Joel ^a   Mu, Yuguang ^a   Baek, Kwanghee ^c   Yoon, Ho Sup ^a,c  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b Agency for Science   (Singapore)

^c Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINYLPROPYLGLYCYLHISTIDINYLTHREONYLPROPYLHISTIDINYLPROPYLALANYLALANINE; GLYCYLPROPYLALANYLLEUCYLSERYLPROPYLVALYLPROPYLPROPYLVALINE; MITOGEN ACTIVATED PROTEIN KINASE 1; PEPTIDYLPROLYL ISOMERASE PIN1; PROPYLLEUCYLGLUTAMINYLTHREONYLPROPYLALANYLALANYLPROPYLGLYCYLALANINE; PROPYLVALYLALANYLARGINYLTHREONYLSERYLPROPYLLEUCYLGLUTAMINYLTHREONINE; PROTEIN BCL 2; SERINE; STRESS ACTIVATED PROTEIN KINASE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONFORMATIONAL TRANSITION; ENZYME SPECIFICITY; HUMAN; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SIMULATION;

AMINO ACID SEQUENCE; HUMANS; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; PEPTIDES; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUBSTRATE SPECIFICITY;

EID: 84871301226     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052047     Document Type: Article

References (38)

1. Cory S, Huang DC, Adams JM, (2003) The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22: 8590-8607.
2. Riedl SJ, Shi Y, (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5: 897-907.
3. Vander Heiden MG, Thompson CB, (1999) Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1: E209-216.
4. Hengartner MO, (2000) The biochemistry of apoptosis. Nature 407: 770-776.
5. Petros AM, Medek A, Nettesheim DG, Kim DH, Yoon HS, et al. (2001) Solution structure of the antiapoptotic protein bcl-2. Proc Natl Acad Sci U S A 98: 3012-3017.
6. Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, et al. (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381: 335-341.
7. Bassik MC, Scorrano L, Oakes SA, Pozzan T, Korsmeyer SJ, (2004) Phosphorylation of BCL-2 regulates ER Ca2+ homeostasis and apoptosis. Embo J 23: 1207-1216.
8. Huang ST, Cidlowski JA, (2002) Phosphorylation status modulates Bcl-2 function during glucocorticoid-induced apoptosis in T lymphocytes. Faseb J 16: 825-832.
9. Breitschopf K, Haendeler J, Malchow P, Zeiher AM, Dimmeler S, (2000) Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Mol Cell Biol 20: 1886-1896.
10. Ruvolo PP, Deng X, May WS, (2001) Phosphorylation of Bcl2 and regulation of apoptosis. Leukemia 15: 515-522.
11. Blagosklonny MV, (2001) Unwinding the loop of Bcl-2 phosphorylation. Leukemia 15: 869-874.
12. Tamura Y, Simizu S, Osada H, (2004) The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria. FEBS Lett 569: 249-255.
13. Mondragon A, Griffith EC, Sun L, Xiong F, Armstrong C, et al. (1997) Overexpression and purification of human calcineurin alpha from Escherichia coli and assessment of catalytic functions of residues surrounding the binuclear metal center. Biochemistry 36: 4934-4942.
14. Shibasaki F, Kondo E, Akagi T, McKeon F, (1997) Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature 386: 728-731.
15. Lu KP, (2004) Pinning down cell signaling, cancer and Alzheimer's disease. Trends Biochem Sci 29: 200-209.
16. Weiwad M, Werner A, Rucknagel P, Schierhorn A, Kullertz G, et al. (2004) Catalysis of Proline-directed Protein Phosphorylation by Peptidyl-prolyl cis/trans Isomerases. Journal of Molecular Biology 339: 635-646.
17. Bayer E, Goettsch S, Mueller JW, Griewel B, Guiberman E, et al. (2003) Structural analysis of the mitotic regulator hPin1 in solution: insights into domain architecture and substrate binding. J Biol Chem 278: 26183-26193.
18. Pathan N, Aime-Sempe C, Kitada S, Basu A, Haldar S, et al. (2001) Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1. Neoplasia 3: 550-559.
19. Kang CB, Tai J, Chia J, Yoon HS, (2005) The flexible loop of Bcl-2 is required for molecular interaction with immunosuppressant FK-506 binding protein 38 (FKBP38). FEBS Lett 579: 1469-1476.
20. Khokhlatchev A, Xu S, English J, Wu P, Schaefer E, et al. (1997) Reconstitution of mitogen-activated protein kinase phosphorylation cascades in bacteria. Efficient synthesis of active protein kinases. J Biol Chem 272: 11057-11062.
21. Smet C, Duckert JF, Wieruszeski JM, Landrieu I, Buee L, et al. (2005) Control of protein-protein interactions: structure-based discovery of low molecular weight inhibitors of the interactions between Pin1 WW domain and phosphopeptides. J Med Chem 48: 4815-4823.
22. Kim S, Cullis DN, Feig LA, Baleja JD, (2001) Solution structure of the Reps1 EH domain and characterization of its binding to NPF target sequences. Biochemistry 40: 6776-6785.
23. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, et al. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6: 277-293.
24. Johnson BA, (2004) Using NMRView to visualize and analyze the NMR spectra of macromolecules. Methods Mol Biol 278: 313-352.
25. Charles DS, Schwieters JJ, Clore GM, (2006) Using Xplor-NIH for NMR molecular structure determination. Prog Nucl Magn Reson Sp 48: 47-62.
26. Lindahl E, Hess B, van der Spoel D, (2001) Gromacs 3.0: A package for molecular simulation and trajectory analysis. J Mol Mod 7: 306-317.
27. Jorgensen WL, Maxwell DS, Tirado-Rives J, (1996) Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids. J Am Chem Soc 118: 11225-11236.
28. Wong SE, Bernacki K, Jacobson M, (2005) Competition between Intramolecular Hydrogen Bonds and Solvation in Phosphorylated Peptides: Simulations with Explicit and Implicit Solvent. J Phys Chem B 109: 5249-5258.
29. Brichese L, Cazettes G, Valette A, (2004) JNK is associated with Bcl-2 and PP1 in mitochondria: paclitaxel induces its activation and its association with the phosphorylated form of Bcl-2. Cell Cycle 3: 1312-1319.
30. Tholey A, Lindemann A, Kinzel V, Reed J, (1999) Direct Effects of Phosphorylation on the Preferred Backbone Conformation of Peptides: A Nuclear Magnetic Resonance Study. Biophys J 76: 76-87.
31. Shen T, Wong CF, McCammon JA, (2001) Atomistic Brownian Dynamics Simulation of Peptide Phosphorylation. J Am Chem Soc 123: 9107-9111.
32. Wintjens R, Wieruszeski JM, Drobecq H, Rousselot-Pailley P, Buee L, et al. (2001) 1H NMR study on the binding of Pin1 Trp-Trp domain with phosphothreonine peptides. J Biol Chem 276: 25150-25156.
33. Barboule N, Truchet I, Valette A, (2005) Localization of phosphorylated forms of Bcl-2 in mitosis: co-localization with Ki-67 and nucleolin in nuclear structures and on mitotic chromosomes. Cell Cycle 4: 590-596.
34. Deng X, Ruvolo P, Carr B, May WS Jr, (2000) Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases. Proc Natl Acad Sci U S A 97: 1578-1583.
35. Kennelly PJ, Krebs EG, (1991) Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J Biol Chem 266: 15555-15558.
36. Gonzalez FA, Raden DL, Davis RJ, (1991) Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J Biol Chem 266: 22159-22163.
37. Zhang J, Zhou B, Zheng CF, Zhang ZY, (2003) A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates. J Biol Chem 278: 29901-29912.
38. Ciechanover A, Schwartz AL, (1994) The ubiquitin-mediated proteolytic pathway: mechanisms of recognition of the proteolytic substrate and involvement in the degradation of native cellular proteins. Faseb J 8: 182-191.